Arkolith/Insider Trading/CRBU/Form 4

Rizvi Syed Ali-aamir

Chief Medical OfficerCaribou Biosciences, Inc. (CRBU) · full profile →Form 4 · filed Jan 20, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$36K
Net Open-Market Flow
-$36K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 19, 2023Sell(S)6K$6.31$36K59K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001619856-23-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML